«You can walk into a lot of our laboratories and the work is the same
as in a pharmaceutical company.»
Not exact matches
In B.C. especially, companies such as QLT Inc., Angiotech Pharmaceuticals and Cardiome Pharma Corp. saw their valuations soar in the early 2000s, only to come crashing to earth by the end of the decade as a result of competitive pressures, regulatory snags, strategic blunders and deals gone awr
In B.C. especially,
companies such
as QLT Inc., Angiotech
Pharmaceuticals and Cardiome Pharma Corp. saw their valuations soar
in the early 2000s, only to come crashing to earth by the end of the decade as a result of competitive pressures, regulatory snags, strategic blunders and deals gone awr
in the early 2000s, only to come crashing to earth by the end of the decade
as a result of competitive pressures, regulatory snags, strategic blunders and deals gone awry.
He headed up Bausch & Lomb until the eye care specialist was snatched up by the (now - infamous) Valeant
Pharmaceuticals (vrx); sat at the top perch of Forest Laboratories before becoming CEO of that
company's acquirer, Actavis,
in 2014; and, finally, took over
as the top dog at Allergan after Actavis bought it and adopted the Botox - maker's name.
«There hasn't really been a platform
company in Canada that has been financed and validated by
as many
pharmaceutical companies,» he says.
Mathers previously served
as CEO of CoLucid
Pharmaceuticals (NASDAQ: CLCD), a Pappas Capital portfolio
company that was acquired in early 2017 by Eli Lilly & Company for nearly $ 1 b
company that was acquired
in early 2017 by Eli Lilly &
Company for nearly $ 1 b
Company for nearly $ 1 billion.
«Britain's importance to the Life Sciences industry, and its status
as a major player
in global science, should mean that irrespective of Brexit, major
pharmaceutical companies continue to see the UK
as a key place to invest,» he said.
Activist hedge fund investor and recent Valeant
Pharmaceuticals (vrx) board appointee Bill Ackman on Wednesday slammed the
company's steep drug price hikes
in testimony before the U.S. Senate Special Committee on Aging, going so far
as to say the cost bumps «contributed to healthcare inflation and called into question the
company's commitment to the patients it serves.»
Martin Shkreli, unaffectionately known
as the «pharma bro» — and infamous for his decision to hike the list price of Daraprim, a drug used by HIV / AIDS and cancer patients to combat infections, by more than 5,000 %
in 2015 under his former
company Turing
Pharmaceuticals — was convicted on three criminal securities fraud and conspiracy charges by a Brooklyn jury on Friday.
Brendan Kennedy, the cofounder of Privateer Holdings, which owns various marijuana
companies like Marley Natural and Canadian
pharmaceutical - grade cannabis producer Tilray, says his
companies are expanding abroad while the U.S. Drug Enforcement Agency and the Food and Drug Administration debate whether or not to treat the plant
as a medicine or keep it
in the same category
as heroin.
Samantha Godfrey, CEO and co-founder of San Diego - based Pharmly, a
pharmaceutical bidding marketplace that graduated from the program
in June, says her
company benefited from mentors who gave guidance for which she would have paid top dollar had she been working on her own,
as well
as from $ 60,000
in credit for Microsoft's Azure cloud platform.
Multinational
pharmaceutical companies are investing
in India,
as they find it a cheap place to manufacture,
as well
as to gain the fringe benefit of the potential huge local - growth opportunity.
He took a job
as a production worker for the
pharmaceutical company in Manitoba while continuing his brokerage business on the side.
It could also see technology
companies start to become
as important a player
in the health - care world
as pharmaceutical companies.
Founded more than two centuries ago by small medicines vendor and namesake Chobei Takeda
in Osaka, Japan, the
company was that nation's largest
pharmaceutical firm by revenue
as of 2014.
Wichmann saw the
company's five main focus areas — health care delivery,
pharmaceutical services, consumer - centric benefits, digitizing health information and global access —
as key drivers
in the shift to more efficient health - care services.
As I've previously reported, Roivant and its federation of biopharma
companies focused on developing drugs
in specific disease spaces is attempting a very new form of
pharmaceutical R&D.
Teva
Pharmaceuticals has proposed buying rival Mylan for $ 40 billion
in cash and stock,
as the Israel - based drugmaker looks to gain dominance among generic
pharmaceutical companies.
The trend to inversions has been particularly strong
in the
pharmaceuticals sector, where many essentially U.S. - based or - focused
companies have shifted their tax domicile to countries such
as Ireland or the Netherlands, which have particularly generous corporate tax regimes, especially
as regards monetizing patent - protected intellectual property.
As Businessweek reports, the case centers on a Japanese
pharmaceutical company called Asahi, which licensed a drug called Fasudil to the San Francisco - based
company CoTherix
in 2006.
Bristol's $ 2.4 billion purchase of Medarex — which
pharmaceutical analysts routinely cite
as one of the best acquisitions
in the history of the industry — would give the
company not only a new blockbuster but also a leadership position
in a burgeoning drug category: immuno - oncology.
In April, Sandow quit his day job as a manager at a pharmaceutical company to concentrate full - time on RxList, which he expects to pull in $ 500,000 in sales this yea
In April, Sandow quit his day job
as a manager at a
pharmaceutical company to concentrate full - time on RxList, which he expects to pull
in $ 500,000 in sales this yea
in $ 500,000
in sales this yea
in sales this year.
I hope so, particularly
in light of
pharmaceutical companies frequently pointing to the high costs of developing new drugs
as being the primary reason prices are so high for existing drugs.
Pomerantz is co-lead counsel
in a securities class action against international
pharmaceutical company Perrigo plc concerning allegations related to the
company misleading investors
as to its revenue growth potential
in order to encourage them to reject a tender offer by Mylan N.V.
In this class action insider trading case, Pomerantz, as Co-Lead Counsel, achieved a $ 135 million settlement for investors in the pharmaceutical company Elan Corp
In this class action insider trading case, Pomerantz,
as Co-Lead Counsel, achieved a $ 135 million settlement for investors
in the pharmaceutical company Elan Corp
in the
pharmaceutical company Elan Corp..
As the CEOs of Shoppers Drug Mart and Rexall, they control the two largest
pharmaceutical companies in English Canada.
The Kamens claim the main thing that distinguishes their foundation from other brain tumor foundations is their focus on pediatric brain cancer specifically,
as well
as their close ties with
pharmaceutical and biotech
companies working
in the fields of immunotherapy and target gene therapy.
Mr. Gorsky left Johnson & Johnson
in 2004 to join the Novartis
Pharmaceuticals Corporation, where he served
as head of the
company's
pharmaceutical business
in North America.
The takeover interest
in Tesaro underscores the
pharmaceutical industry's strong appetite for the acquisition of biotechnology
companies with promising medicines under development
in lucrative sectors such
as cancer treatment.
He represents
pharmaceutical companies both large and small on a myriad of issues,
as well
as several universities
in both patenting and licensing to outside investors.
NEW YORK (Reuters)- Twenty - eight year old Margaret Davis was making nice money
as a writer
in the legal department of a big
pharmaceutical company in New York.
She co-founded and last served
as CEO for Sprout
Pharmaceuticals where,
in 2015, the
company broke through with the first ever FDA - approved drug for low sexual desire
in women — dubbed «female Viagra» by the media.
Art has over 30 years of operating experience
as a
pharmaceutical and biotechnology industry executive and venture capital investor
in life science
companies.
The spectacle that Shkreli created around himself and his
company Turing
Pharmaceuticals since late summer, even
as the criminal probe proceeded, raised the question of whether he had any idea of the risk he was running — or whether his conduct was part of a plan to beat the rap
in Brooklyn federal court and generate business.
«We are pleased to share this vision with the unique blend of crossover funds,
pharmaceutical companies, and venture capital investors participating
in our Series B, and look forward to advancing our position
as the leading biotech with a dual focus on synthetic lethality and immuno - oncology.»
«Our proposal would provide Teva stockholders with very attractive strategic and financial benefits and Mylan stockholders with a substantial premium and immediate value for their shares,
as well
as the opportunity to participate
in the significant upside potential of the combined
company — one that would transform the global generics space and leverage it to hold a unique leadership position
in the
pharmaceutical industry.
In some cases, Cohodes» battles against Canadian companies have turned personal, as is the case with Concordia International, the pharmaceutical firm headquartered in Oakville, Ontari
In some cases, Cohodes» battles against Canadian
companies have turned personal,
as is the case with Concordia International, the
pharmaceutical firm headquartered
in Oakville, Ontari
in Oakville, Ontario.
J&J ranks
as the single largest healthcare
company in the world, with operations including
pharmaceuticals, consumer healthcare, and medical devices.
International
companies — such
as pharmaceutical or technology firms — shelter income abroad to avoid taxes
in the United States.
It is hard to believe, for example, that Canada could not
in the end find common ground with the US on some extension of patent protection for
pharmaceuticals, since it was able to do so
in the just - completed negotiations with the EU, or that an extension of the term of copyright protection from 50 to 70 years from the agreed baseline would have much if any real practical impact on Canada although it would be seen
as a gain by the US given the heavy copyright portfolios of US entertainment
companies, allowing them an additional period of time to exploit their copyrighted content.
When this happens, it could be a very difficult time for the
pharmaceutical industry, which makes the time before the cliff all the more important
as companies scramble to shore up their product lines and get their balance sheets
in order before their products lose their patent protection [see also Is Your Biotech ETF A Leader Or Laggard?].
J&J generates billions of dollars
in annual sales from selling consumer goods, such
as Band - Aid products, and medical devices used
in surgeries, but it's the
company's
pharmaceuticals business that determines whether the
company's results are better or worse than anticipated.
Pfizer (NYSE: PFE) ranks
as one of the biggest
pharmaceutical companies in the world.
With several drugs currently acting
as significant drivers of growth, J&J's
pharmaceutical segment looks well placed even
as the
company strives to maintain its market share
in consumer healthcare and medical devices.
As of December 29, 2017, the Growth
Company Fund held 6.7 % of assets
in Nvidia Corp, 4.7 %
in Amazon.com, Inc., 2.3 %
in Microsoft, Corp., 2 %
in Alphabet, Inc., 1.5 %
in Alnylam
Pharmaceuticals, Inc., and 1.1 %
in bluebird bio, Inc..
Azar left the
pharmaceutical company Eli Lilly
in January after working there for nearly a decade, most recently serving
as the president of Lilly USA.
The
company makes relatively small acquisitions from time to time, such
as its $ 3.6 billion cash purchase of King
Pharmaceuticals in 2011.
Forbion invests
in life sciences
companies that are active
in the
pharmaceutical,
as well
as the medical device space.
In 2006, the full brunt of the breaks» removal hit, and manufacturers, in particular pharmaceutical companies, began closing plants; an estimated 100,000 manufacturing jobs have been lost, with more indirect jobs going away as a resul
In 2006, the full brunt of the breaks» removal hit, and manufacturers,
in particular pharmaceutical companies, began closing plants; an estimated 100,000 manufacturing jobs have been lost, with more indirect jobs going away as a resul
in particular
pharmaceutical companies, began closing plants; an estimated 100,000 manufacturing jobs have been lost, with more indirect jobs going away
as a result.
As shown
in the same merger document,
pharmaceutical services
companies tended to be taken over at an EV / EBITDA of 12 and P / E of 23.
While there is still some debate
as to what causes these disorders
in children, the intervention of natural medicine, rather than those mass - produced by
pharmaceutical companies, is being used more and more throughout treatment programs.